Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma
(Q77378845)
scientific article published on 01 December 2001
scientific article published on 01 December 2001
Language:
Current Data About
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma
other details
description | scientific article published on 01 December 2001 |
External Links
(P356) |
10.1038/SJ.LEU.2402302
|
(P698) |
11753616
|
(P6179) |
1035035716
|